Cargando…

Treatment strategies for hyperkalemia secondary to urethral obstruction in 50 male cats: 2002–2017

OBJECTIVES: The aims of this study were: to describe the potassium-lowering treatment strategies used to manage moderate-to-severe hyperkalemia in male cats with urethral obstruction (UO); to determine how much dextrose was required per unit of insulin to prevent hypoglycemia; to determine whether e...

Descripción completa

Detalles Bibliográficos
Autores principales: Jones, Jessica M, Burkitt-Creedon, Jamie M, Epstein, Steven E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9742918/
https://www.ncbi.nlm.nih.gov/pubmed/36350735
http://dx.doi.org/10.1177/1098612X221127234
_version_ 1784848622875049984
author Jones, Jessica M
Burkitt-Creedon, Jamie M
Epstein, Steven E
author_facet Jones, Jessica M
Burkitt-Creedon, Jamie M
Epstein, Steven E
author_sort Jones, Jessica M
collection PubMed
description OBJECTIVES: The aims of this study were: to describe the potassium-lowering treatment strategies used to manage moderate-to-severe hyperkalemia in male cats with urethral obstruction (UO); to determine how much dextrose was required per unit of insulin to prevent hypoglycemia; to determine whether early initiation of a dextrose continuous rate infusion (CRI) prevented hypoglycemia; and to determine whether in-hospital mortality was associated with presenting plasma potassium concentration ([K(+)]). METHODS: The medical records of male cats presenting with a [K(+)] ⩾7.0 mEq/l due to UO that had another [K(+)] measured within 6 h were reviewed retrospectively. All [K(+)] values within the first 6 h, blood glucose concentrations, treatments for hyperkalemia and survival to discharge were recorded. Analyses were performed to test for associations between dextrose:insulin ratios or method of dextrose administration and the development of hypoglycemia; and for presenting [K(+)] and mortality. Normally distributed groups of continuous data were compared with a t-test and categorical data were compared with a Fisher’s exact test. RESULTS: Fifty cats were included. Mean presenting [K(+)] was 8.9 ± 1.0 mEq/l, while the mean final [K(+)] within 6 h was 6.6 ± 1.4 mEq/l. Forty-two (84%) cats were treated with intravenous fluids and 40 (80%) were treated with dextrose and insulin. Median dextrose:insulin ratio was 2 g/u (range 0.4–100). No dextrose:insulin ratio was found to protect against hypoglycemia, and 3/8 cats that became hypoglycemic had received ⩾2 g dextrose per unit of insulin. There was no association between the early initiation of a dextrose-containing CRI and avoidance of hypoglycemia. No association was found between presenting [K(+)] and mortality. CONCLUSIONS AND RELEVANCE: While no specific dextrose:insulin ratio was found to protect against hypoglycemia, there is evidence that the commonly recommended dextrose:insulin ratio of 2 g/u may be inadequate in preventing hypoglycemia in every cat. Severity of hyperkalemia was not associated with mortality.
format Online
Article
Text
id pubmed-9742918
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-97429182022-12-13 Treatment strategies for hyperkalemia secondary to urethral obstruction in 50 male cats: 2002–2017 Jones, Jessica M Burkitt-Creedon, Jamie M Epstein, Steven E J Feline Med Surg Original Articles OBJECTIVES: The aims of this study were: to describe the potassium-lowering treatment strategies used to manage moderate-to-severe hyperkalemia in male cats with urethral obstruction (UO); to determine how much dextrose was required per unit of insulin to prevent hypoglycemia; to determine whether early initiation of a dextrose continuous rate infusion (CRI) prevented hypoglycemia; and to determine whether in-hospital mortality was associated with presenting plasma potassium concentration ([K(+)]). METHODS: The medical records of male cats presenting with a [K(+)] ⩾7.0 mEq/l due to UO that had another [K(+)] measured within 6 h were reviewed retrospectively. All [K(+)] values within the first 6 h, blood glucose concentrations, treatments for hyperkalemia and survival to discharge were recorded. Analyses were performed to test for associations between dextrose:insulin ratios or method of dextrose administration and the development of hypoglycemia; and for presenting [K(+)] and mortality. Normally distributed groups of continuous data were compared with a t-test and categorical data were compared with a Fisher’s exact test. RESULTS: Fifty cats were included. Mean presenting [K(+)] was 8.9 ± 1.0 mEq/l, while the mean final [K(+)] within 6 h was 6.6 ± 1.4 mEq/l. Forty-two (84%) cats were treated with intravenous fluids and 40 (80%) were treated with dextrose and insulin. Median dextrose:insulin ratio was 2 g/u (range 0.4–100). No dextrose:insulin ratio was found to protect against hypoglycemia, and 3/8 cats that became hypoglycemic had received ⩾2 g dextrose per unit of insulin. There was no association between the early initiation of a dextrose-containing CRI and avoidance of hypoglycemia. No association was found between presenting [K(+)] and mortality. CONCLUSIONS AND RELEVANCE: While no specific dextrose:insulin ratio was found to protect against hypoglycemia, there is evidence that the commonly recommended dextrose:insulin ratio of 2 g/u may be inadequate in preventing hypoglycemia in every cat. Severity of hyperkalemia was not associated with mortality. SAGE Publications 2022-11-09 2022-12 /pmc/articles/PMC9742918/ /pubmed/36350735 http://dx.doi.org/10.1177/1098612X221127234 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/This article is distributed under the terms of the Creative Commons Attribution 4.0 License (https://creativecommons.org/licenses/by/4.0/) which permits any use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Original Articles
Jones, Jessica M
Burkitt-Creedon, Jamie M
Epstein, Steven E
Treatment strategies for hyperkalemia secondary to urethral obstruction in 50 male cats: 2002–2017
title Treatment strategies for hyperkalemia secondary to urethral obstruction in 50 male cats: 2002–2017
title_full Treatment strategies for hyperkalemia secondary to urethral obstruction in 50 male cats: 2002–2017
title_fullStr Treatment strategies for hyperkalemia secondary to urethral obstruction in 50 male cats: 2002–2017
title_full_unstemmed Treatment strategies for hyperkalemia secondary to urethral obstruction in 50 male cats: 2002–2017
title_short Treatment strategies for hyperkalemia secondary to urethral obstruction in 50 male cats: 2002–2017
title_sort treatment strategies for hyperkalemia secondary to urethral obstruction in 50 male cats: 2002–2017
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9742918/
https://www.ncbi.nlm.nih.gov/pubmed/36350735
http://dx.doi.org/10.1177/1098612X221127234
work_keys_str_mv AT jonesjessicam treatmentstrategiesforhyperkalemiasecondarytourethralobstructionin50malecats20022017
AT burkittcreedonjamiem treatmentstrategiesforhyperkalemiasecondarytourethralobstructionin50malecats20022017
AT epsteinstevene treatmentstrategiesforhyperkalemiasecondarytourethralobstructionin50malecats20022017